Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Matzinger M., Fischhuber K., Heiss EH.

Narrative Review on Type 2 Diabetes, published in Biotechnol Adv (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biotechnol Adv (2018)
Reported sample size
—
Source database
Europe PMC
PMID
29289692
PMCID
PMC5967606
DOI
10.1016/j.biotechadv.2017.12.015
Citations
142

Abstract (original English)

Type 2 diabetes mellitus (DM) has reached pandemic proportions and effective prevention strategies are wanted. Its onset is accompanied by cellular distress, the nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor boosting cytoprotective responses, and many phytochemicals activate Nrf2 signaling. Thus, Nrf2 activation by natural products could presumably alleviate DM. We summarize function, regulation and exogenous activation of Nrf2, as well as diabetes-linked and Nrf2-susceptible forms of cellular stress. The reported amelioration of insulin resistance, β-cell dysfunction and diabetic complications by activated Nrf2 as well as the status quo of Nrf2 in precision medicine for DM are reviewed.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMice, KnockoutHumansMiceDiabetes Mellitus, Type 2Blood GlucoseBiological ProductsHypoglycemic AgentsSignal TransductionNF-E2-Related Factor 2

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research